Skip to main content

Month: July 2023

Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Guerbet wins PI-CAI Grand Challenge on detection of prostate cancerVillepinte, 17 July 2023: Guerbet (FR0000032526 GBT), a global specialist in contrast media and medical imaging solutions, is delighted to announce the success of its teams at the PI-CAI (Prostate Imaging: Cancer Al) Grand Challenge1, an international challenge organised by a consortium2 of radiology opinion leaders in prostate imaging, urologists and artificial intelligence experts, to compare the performance of artificial intelligence algorithms in the detection of prostate cancer. Diagnosis of prostate cancer, a public health issue The second male cancer according to the WHO, prostate cancer, with 1.4 million new cases each year worldwide, accounts for 6.8% of male cancer-related deaths (350,000 deaths per year). Currently, only 10% to 20% of patients are diagnosed...

Continue reading

Gentherm Announces Date for 2023 Second Quarter Results News Release and Conference Call

NORTHVILLE, Mich., July 17, 2023 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, will report its financial results for the second quarter 2023 at 6 am (ET) on Tuesday, August 1, 2023, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018 International dial-in number: 1-201-689-8471Conference ID number: 13739903 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm’s website at www.gentherm.com. A telephonic replay will be available approximately two hours after the call...

Continue reading

Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV diseaseBeyfortus™ is the first monoclonal antibody approved to protect all infants through their first RSV season Across all clinical endpoints, a single dose of Beyfortus delivered high, consistent and sustained efficacy and favorable safety against RSV disease Approval also includes use for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV seasonParis, July 17, 2023. The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus™ (nirsevimab-alip) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain...

Continue reading

IBEX Technologies Announces Renewal of Normal Course Issuer Bid

MONTREAL, July 17, 2023 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today announced that the TSX Venture Exchange (“TSXV”) has conditionally approved the renewal of IBEX’s normal course issuer bid (“NCIB”). Under the renewed NCIB, IBEX may purchase for cancellation a maximum of 1,500,000 common shares, representing approximately 9.9% of the 15,163,667 shares forming IBEX’s public float. The shares may be purchased through the facilities of the TSXV. The renewed NCIB will commence on August 5, 2023 and end on the earlier of August 4, 2024 and the date on which IBEX completes the purchase of the maximum number of 1,500,000 common shares pursuant to the NCIB. As of July 14, 2023, IBEX had 24,758,644 common shares issued and outstanding. Under its current NCIB, which ends on August 4, 2023,...

Continue reading

Form 8.3 – Amended Form 8.3 Emis Group PLC

FORM 8.3 *AMENDED TO REPLACE FILING OF 17 JULY 2023 (CHANGES TO SECTION 3(a) AND 3(b)) DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: P. Schoenfeld Asset Management LLP(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree EMIS Group plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date...

Continue reading

Ipsos acquires Big Village Australia

Ipsos acquires Big Village Australia Building on capabilities in Public Affairs and large-scale data collection Paris, July 17th, 2023 – Ipsos is pleased to announce the acquisition of the Insights business of Big Village Australia, covering public sector market research, employee research and customer experience. The acquisition enhances Ipsos’ position in the Australian market and strengthens its capabilities in the government and social sectors as well as customer and employee experience. It also contributes to Ipsos 2025 growth plan, strengthening the global public affairs business. The acquisition is highly complementary to Ipsos’ existing research expertise, bringing large-scale federal government programs. Big Village Australia teams also service multinational clients in the professional services and IT sectors on customer...

Continue reading

Perma-Fix Partners with UA Plumbers & Steamfitters Local 598 to Provide Safe and Reliable Option For Hanford Tank Waste Grouting and Disposal

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced it held a Project Labor Agreement (PLA) signing event with UA Plumbers & Steamfitters Local 598, on July 14, 2023. The goal of this partnership is to supply the Perma-Fix Northwest Facility (PFNW) with the organized labor force needed to take on the challenges of providing a supplement treatment alternative to include concrete-like grout for Hanford’s Low Activity Tank Waste. This supplemental capability would support U.S. Department of Energy’s (DOE) glassifying process provided by the Hanford Vitrification Plant for safe transport and disposal off-site. A number of key government officials and community leaders attended the event to express support for the project. The U.S. Department of...

Continue reading

Aramis Group – 2023 third-quarter activity

PRESS RELEASE Arcueil, July 17, 2023 2023 third-quarter activity Rising volumes in a sluggish marketPursuing the strategy of profitable growth Revenues at June 30, 2023, third quarter of the financial year ending September 30, 20232023 third-quarter revenues of €489.0 million, up +6.8% on a reported basis from the third quarter of 2022Very high levels of client satisfaction maintained, with an NPS1 at June 30, 2023 of 73 (+3 points versus March 31, 2023), reflecting the dedication shown by the Group’s teamsTotal volumes of B2C vehicles sold over the quarter up +12.1% on a reported basis to 23,087 units. Excluding the acquisitions in Austria and Italy, growth came to +1.4%Significant upturn in pre-registered vehicle volumes, climbing +66.9% compared with the third quarter of 2022, supported by business virtually doubling in France,...

Continue reading

RocketFuel and Poncho Brotherz Announce Partnership to Accept Cryptocurrency Payments

Premier Cannabis Retailer Joins Digital Currency Revolution San Francisco, July 17, 2023 (GLOBE NEWSWIRE) — RocketFuel, Inc. (OTCQB: RKFL) (“RocketFuel” or the “Company”), a global provider of payment solutions via ACH bank transfers, Bitcoin and other cryptocurrencies, announced a collaboration with Poncho Brotherz, a leading family-owned and operated farm-to-retail cannabis retail store. This collaboration will enable Poncho Brotherz to accept cryptocurrency payments in its dispensary, marking a significant step forward in embracing the digital currency revolution. With RocketFuel’s innovative blockchain technology, Poncho Brotherz customers can now make purchases using over 160 different cryptocurrencies, including Bitcoin. This new payment option not only simplifies the checkout process but also makes it more secure and...

Continue reading

ASM share buyback update July 10 – 14, 2023

Almere, The Netherlands July 17, 2023, 5:45 p.m. CET ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASM’s current share buyback program.Date Repurchased shares Average price Repurchased valueJuly 10, 2023 2,376 € 372.20 € 884,340Total 2,376 € 372.20 € 884,340These repurchases were made as part of the €100 million share buyback program which started on April 27, 2023. Of the total program, 55.7% has been repurchased. For further details including individual transaction information please visit: www.asm.com/investors/dividends-share-buybacks. About ASM International ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.